News

OXiGENE said that an updated safety and outcome analysis of the Falcon trial has shown that trends towards improved outcomes were observed in response rate, progression-free survival and

According to the Mymetics, in the Phase Ib trial conducted in cooperation with the Swiss Tropical and Public Health Institute (Swiss TPH) and Pevion Biotech, the vaccine was

The technology is expected to be one of the cornerstones of Oncodesign’s integrated drug discovery efforts, together with the in vitro and in vivo translational research capabilities in

Velcade (bortezomib) is a medicine used to treat the blood based cancer known as multiple myeloma. It contains an active substance called Bortezomib and is the first in

Tibco is going to demonstrate a beta version of the product at the 46th Drug Information Association (DIA) Annual Meeting in Washington. Tibco Software said that the Spotfire

The double-blind pivotal study is expected to compare the efficacy and safety of once-daily oral administration of 200 mg of Torezolid Phosphate over six days of treatment to

According to the invention 4460446 patent disclosure, the compounds are useful in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer’s disease, Attention deficient hyperactivity disorder

Axxess Pharma claimed that it would also be the first company to introduce a unique herbal, non-alcohol based antiseptic hand wash and disinfectant to the Canadian market. Axxess

Levetiracetam injection is indicated as adjunctive therapy in the treatment of partial onset seizures in adults with epilepsy. It is also indicated as adjunctive therapy in the treatment